Status:
RECRUITING
The Effect of Tucking on Semen Quality of Adult Trans Women
Lead Sponsor:
Medical University Innsbruck
Conditions:
Transgender
Gender Incongruence
Eligibility:
MALE
18-50 years
Brief Summary
Because gender-affirming hormone therapy (GAHT) can lead to fertility impairment, current guidelines and treatment recommendations require that patients be informed about the possibility of fertility ...
Eligibility Criteria
Inclusion
- Female transgender patients between the ages of 18 to 50 years of age who are seen at the University Clinic for Gyn. Endocrinology and Reproductive Medicine of the Medical University of Innsbruck. Patients must have met the eligibility and readiness criteria for gender-affirming hormone therapy
Exclusion
- Ongoing GAHT gender affirming genital surgery Hypogonadism Diabetes mellitus Cystic Fibrosis Varicocele Cryptorchism Post-sterilization Incapacity to consent
Key Trial Info
Start Date :
July 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06530992
Start Date
July 17 2024
End Date
December 1 2029
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University clinic for Gynecological Endocrinology and Reproductive Medicine Department of Gynecology Medical University of Innsbruck
Innsbruck, Austria